{"blog": [], "keywords": [{"value": "Mylan Inc", "name": "organizations", "rank": "1", "is_major": "Y"}, {"value": "Epinephrine (Drug)", "name": "subject", "rank": "2", "is_major": "Y"}, {"value": "Lobbying and Lobbyists", "name": "subject", "rank": "3", "is_major": "N"}, {"value": "Prices (Fares, Fees and Rates)", "name": "subject", "rank": "4", "is_major": "N"}, {"value": "Law and Legislation", "name": "subject", "rank": "5", "is_major": "N"}, {"value": "Health Insurance and Managed Care", "name": "subject", "rank": "6", "is_major": "Y"}, {"value": "United States Preventive Services Task Force", "name": "organizations", "rank": "7", "is_major": "N"}], "web_url": "http://www.nytimes.com/2016/09/16/business/epipen-maker-mylan-preventative-drug-campaign.html", "document_type": "article", "byline": {"person": [{"lastname": "LIPTON", "firstname": "Eric", "role": "reported", "organization": "", "rank": 1}, {"lastname": "ABRAMS", "firstname": "Rachel", "role": "reported", "organization": "", "rank": 2}], "original": "By ERIC LIPTON and RACHEL ABRAMS", "contributor": ""}, "type_of_material": "News", "multimedia": [{"url": "images/2016/09/16/business/16epipenlobby-1/16epipenlobby-1-thumbWide.jpg", "legacy": {"wide": "images/2016/09/16/business/16epipenlobby-1/16epipenlobby-1-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "subtype": "wide", "type": "image", "width": 190, "height": 126}, {"url": "images/2016/09/16/business/16epipenlobby-1/16epipenlobby-1-articleLarge.jpg", "legacy": {"xlarge": "images/2016/09/16/business/16epipenlobby-1/16epipenlobby-1-articleLarge.jpg", "xlargeheight": "391", "xlargewidth": "600"}, "subtype": "xlarge", "type": "image", "width": 600, "height": 391}, {"url": "images/2016/09/16/business/16epipenlobby-1/16epipenlobby-1-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/09/16/business/16epipenlobby-1/16epipenlobby-1-thumbStandard.jpg", "thumbnailheight": "75", "thumbnailwidth": "75"}, "subtype": "thumbnail", "type": "image", "width": 75, "height": 75}], "section_name": "Business Day", "word_count": "2082", "source": "The New York Times", "subsection_name": null, "lead_paragraph": "Inclusion on a federal list would mean Mylan could keep its list price high \u2014 or even raise it \u2014 without patients\u2019 complaining. But consumers would feel it indirectly.", "pub_date": "2016-09-16T07:30:34+0000", "news_desk": "Business", "headline": {"print_headline": "Tactic by Maker of EpiPen Could Quell Protests", "main": "EpiPen Maker Lobbies to Shift High Costs to Others"}, "print_page": "1", "snippet": "Inclusion on a federal list would mean Mylan could keep its list price high \u2014 or even raise it \u2014 without patients\u2019 complaining. But consumers would feel it indirectly....", "_id": "57db9f9f95d0e021d7986943", "slideshow_credits": null, "abstract": null}